PI4K2A
Basic information
Region (hg38): 10:97640671-97676434
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with hyperkinetic movements, seizures and structural brain abnormalities | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 30564627; 32418222; 35880319 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PI4K2A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 18 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 0 | 0 |
Variants in PI4K2A
This is a list of pathogenic ClinVar variants found in the PI4K2A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-97640746-G-A | not specified | Uncertain significance (Jun 23, 2023) | ||
10-97640786-C-T | not specified | Uncertain significance (Jan 19, 2022) | ||
10-97640807-C-A | Neurodevelopmental disorder with hyperkinetic movements, seizures, and structural brain abnormalities | Pathogenic (Feb 29, 2024) | ||
10-97640921-C-T | not specified | Uncertain significance (Aug 10, 2021) | ||
10-97640948-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
10-97640996-C-T | not specified | Uncertain significance (Aug 02, 2022) | ||
10-97640999-C-T | not specified | Uncertain significance (Apr 29, 2024) | ||
10-97641105-C-G | not specified | Uncertain significance (May 07, 2024) | ||
10-97641169-C-T | not specified | Uncertain significance (May 03, 2023) | ||
10-97650941-A-G | not specified | Uncertain significance (Sep 29, 2022) | ||
10-97650990-T-G | not specified | Uncertain significance (Nov 15, 2021) | ||
10-97651134-G-A | not specified | Uncertain significance (Mar 01, 2023) | ||
10-97656365-G-T | not specified | Uncertain significance (Apr 29, 2024) | ||
10-97656843-T-C | not specified | Uncertain significance (Sep 07, 2022) | ||
10-97656845-G-A | not specified | Uncertain significance (Jun 07, 2024) | ||
10-97656887-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
10-97656914-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
10-97656926-C-G | not specified | Uncertain significance (Jan 11, 2023) | ||
10-97656938-C-T | not specified | Uncertain significance (May 23, 2023) | ||
10-97662909-C-T | Neurodevelopmental disorder with hyperkinetic movements, seizures, and structural brain abnormalities | Pathogenic (Feb 29, 2024) | ||
10-97662948-A-G | not specified | Uncertain significance (May 08, 2024) | ||
10-97662966-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
10-97666533-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
10-97673615-A-G | not specified | Uncertain significance (Apr 22, 2022) | ||
10-97673650-A-G | not specified | Uncertain significance (Mar 29, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PI4K2A | protein_coding | protein_coding | ENST00000370631 | 9 | 92061 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.804 | 0.196 | 125738 | 0 | 8 | 125746 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.89 | 129 | 260 | 0.496 | 0.0000143 | 3086 |
Missense in Polyphen | 30 | 97.665 | 0.30717 | 1194 | ||
Synonymous | 1.97 | 77 | 102 | 0.752 | 0.00000522 | 960 |
Loss of Function | 3.67 | 4 | 23.0 | 0.174 | 0.00000113 | 254 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000867 | 0.0000867 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Membrane-bound phosphatidylinositol-4 kinase (PI4- kinase) that catalyzes the phosphorylation of phosphatidylinositol (PI) to phosphatidylinositol 4-phosphate (PI4P), a lipid that plays important roles in endocytosis, Golgi function, protein sorting and membrane trafficking and is required for prolonged survival of neurons. Besides, phosphorylation of phosphatidylinositol (PI) to phosphatidylinositol 4-phosphate (PI4P) is the first committed step in the generation of phosphatidylinositol 4,5-bisphosphate (PIP2), a precursor of the second messenger inositol 1,4,5-trisphosphate (InsP3). {ECO:0000269|PubMed:11279162, ECO:0000269|PubMed:16443754, ECO:0000269|PubMed:20388919, ECO:0000269|PubMed:23146885, ECO:0000269|PubMed:24675427, ECO:0000269|PubMed:25168678, ECO:0000305}.;
- Pathway
- Inositol phosphate metabolism - Homo sapiens (human);Phosphatidylinositol signaling system - Homo sapiens (human);Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway;Wnt Signaling Pathway;D-<i>myo</i>-inositol (1,4,5)-trisphosphate biosynthesis;Metabolism of lipids;Metabolism;3-phosphoinositide biosynthesis;superpathway of inositol phosphate compounds;Synthesis of PIPs at the Golgi membrane;Synthesis of PIPs at the early endosome membrane;Synthesis of PIPs at the plasma membrane;PI Metabolism;Phospholipid metabolism;Canonical Wnt signaling pathway
(Consensus)
Intolerance Scores
- loftool
- 0.102
- rvis_EVS
- 0.55
- rvis_percentile_EVS
- 81.38
Haploinsufficiency Scores
- pHI
- 0.539
- hipred
- Y
- hipred_score
- 0.626
- ghis
- 0.488
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.876
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pi4k2a
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- basophil degranulation;phosphatidylinositol biosynthetic process;Golgi organization;endosome organization;phosphatidylinositol phosphorylation
- Cellular component
- mitochondrion;lysosomal membrane;endosome;trans-Golgi network;cytosol;plasma membrane;integral component of plasma membrane;membrane;cell junction;dendrite;synaptic vesicle membrane;BLOC-1 complex;intrinsic component of membrane;cytoplasmic vesicle;early endosome membrane;growing cell tip;presynaptic membrane;neuron projection;neuronal cell body;perikaryon;host cell presynaptic membrane;membrane raft
- Molecular function
- magnesium ion binding;1-phosphatidylinositol 4-kinase activity;protein binding;ATP binding;AP-3 adaptor complex binding